ALK and neuroblastoma: ALK expression in NB was first described by Lamant and colleagues [22] and more recently we and others reported that wild type ALK is frequently overexpressed in metastatic NB and that, similarly to activating ALK mutations, its overexpression is correlated with poor clinical outcome [23, 24].